Consenso uruguayo de manejo del infarto agudo de ... - SciELO

Weidinger G, et al. The effect of fluvastatin on cardiac events in patients
with symptomatic coronary artery disease during one year of treatment.
Atherosclerosis 1999; 144: 263-70.
204. The Post Coronary Artery Bypass Graft Trial Investigators. The
effect of aggressive lowering of low-density lipoprotein cholesterol levels
and low-dose anticoagulation on obstructive changes in saphenous-vein
coronary-artery bypass grafts. N Engl J Med 1997; 336: 153-62.
205. Knatterud GL, Rosenberg Y, Campeau L, Geller NL,
Hunninghake DB, Forman SA, et al. Long-term effects on clinical
outcomes of aggressive lowering of low-density lipoprotein cholesterol
levels and low-dose anticoagulation in the post coronary artery bypass graft
trial: Post CABG Investigators. Circulation 2000; 102: 157-65.
206. Heart Protection Study (HPS) trial investigators. MRC/BHF
Heart Protection Study of cholesterol lowering with Randomised trial of
cholesterol lowering in 4444 patients with simvastatin in 20,536 high-risk
individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
207. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield
M, et al; ASCOT investigators. Prevention of coronary and stroke events
with atorvastatin in hypertensive patients who have average or lower-thanaverage
cholesterol concentrations, in the Anglo-Scandinavian Cardiac
Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre
randomised controlled trial. Lancet 2003; 361: 1149-58.
208. Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R,
Fischer F, et al. Beneficial effects of pravastatin (+/-colestyramine/niacin)
initiated immediately after a coronary event (the randomized Lipid-
Coronary Artery Disease [L-CAD] Study). Am J Cardiol 2000; 86: 1293-8.
209. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF,
Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in
acute coronary syndromes: the MIRACL study: a randomized controlled
trial. JAMA 2001; 285: 1711-8.
210. Stenestrand U, Wallentin L for the Swedish Register of Cardiac
Intensive Care (RIKS-HIA). Early statin treatment following acute
myocardial infarction and 1-year survival. JAMA 2001; 285: 430-6.
211. Topol EJ. Intensive statin theraphy: a sea change in cardiovascular
prevention [Editorial]. N Engl J Med 2004; 350(15): 1562-4.
212. Aronow HD, Novaro GM, Lauer MS, Brennan DM, Lincoff AM,
Topol EJ, et al. In-hospital initiation of lipid-lowering therapy after
coronary intervention as a predictor of long-term utilization: a propensity
analysis. Arch Intern Med 2003; 163: 2576-82.
213. Hulley S, Grady D, Bush T, et al, for the Heart and
Estrogen/progestin Replacement Study (HERS) Research Group.
Randomized trial of estrogen plus progestin for secondary prevention of
coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-
13.
214. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M,